TNF and rheumatoid arthritis: These authors performed a large pharmacogenetic study including 388 Caucasian RA patients, providing evidence that patients who were homozygous for a single TNF locus haplotype (-238G/-308G/-857C) showed a lower response to adalimumab, mainly when such a drug was combined with MTX [125].